Opus Bank announced its Merchant Banking division, through Opus Financial Partners, served as financial advisor to ProPharma Group Holdings, LLC (“ProPharma Group”), a leading provider of outsourced medical information, pharmacovigilance, and compliance consulting services to customers in the pharmaceutical, biotechnology, and medical device industries, in its sale to Linden Capital Partners (“Linden”), a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life sciences industries.
Jeff Hargroves, Founder, Chief Executive Officer and President of ProPharma Group stated, “We are excited to partner with Linden. Their healthcare expertise and proven track record makes them the right partner as we embark on the next phase of our growth strategy. Linden understands our culture, market and customers and can support our Company with both organic growth and acquisition initiatives.”
Paul Kacik, Managing Director and Head of Healthcare Merchant Banking at Opus Financial Partners added, “ProPharma Group has a long-standing history of providing a uniquely differentiated and comprehensive suite of services for clients in the pharmaceutical and life sciences industries. We are very pleased to have had the opportunity to work with the ProPharma team and guide them through this important milestone. We look forward to following Jeff Hargroves and the entire ProPharma Group management team as they partner with an exceptional group of operating and investment professionals at Linden and continue to grow and realize their long-term vision for the company.”
ProPharma Group is a leading provider of medical information, pharmacovigilance, and compliance consulting services to clients in the pharmaceutical, biotechnology and medical device industries. The company provides outsourced Medical Information and Pharmacovigilance services to respond to product-related medical information inquiries from both medical professionals and patients.
Opus Bank’s Merchant Banking division is an integrated principal investing and financial advisory platform that provides a broad range of direct investment and advisory solutions to lower middle-market companies.